S&P 500 5,235.18 +1.02%EUR/USD 1.0840 +0.21%GBP/USD 1.2710 +0.14%USD/JPY 149.50 −0.18%BRENT $82.40 −0.81%BTC $67,800 −0.21%GOLD $2,341 +0.55%NASDAQ 16,420.55 +0.74%S&P 500 5,235.18 +1.02%EUR/USD 1.0840 +0.21%GBP/USD 1.2710 +0.14%USD/JPY 149.50 −0.18%BRENT $82.40 −0.81%BTC $67,800 −0.21%GOLD $2,341 +0.55%NASDAQ 16,420.55 +0.74%
A daily business newspaper · Founded in 2026

Money Talk

Finance and markets: business, quotes, gold, energy and releases.

Pomerantz Law Firm Probes Calumet Over Securities Fraud Allegations

A 5.73% single-day stock drop following Calumet, Inc.'s second-quarter earnings report has triggered a formal investigation by Pomerantz LLP. Attorneys are now scrutinizing whether the company’s leadership misled investors regarding financial performance, specifically concerning significant margin losses and shifts in production timelines at its Montana Renewables business.

Pomerantz Law Firm Probes Calumet Over Securities Fraud Allegations
Photo: Bio & News

The investigation centers on disclosures made by the company on August 7, 2026. Calumet reported a $6.2 million decline in adjusted EBITDA for its Performance Brands segment, citing timing issues between input cost spikes and pricing adjustments. Simultaneously, the firm revealed that the Montana Renewables business suffered a $40 million impact due to downtime from the MaxSAF expansion, restricting its contribution to just $17 million in adjusted EBITDA.

Management also announced a strategic shift to defer the full ramp-up of sustainable aviation fuel production. The company opted to prioritize an additional $50 million in EBITDA at its conventional refinery before proceeding with asset reconfiguration, a move that effectively delays higher production yields. Investors concerned about these practices or potential breaches of fiduciary duty are directed to contact Danielle Peyton at Pomerantz LLP to discuss their legal standing.

Share article
TelegramXFacebook

When reusing this material a link to Money Talk is required.

Comments (0)

Leave a comment

No comments yet. Be the first!